SCHEMBL5956442

SCHEMBL5956442

Cc1cccc(-c2nc(N)sc2-c2ccnc(-c3ccc(OC(F)(F)F)cc3)c2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 14/20 0.59
MAPK14 Q16539 3/20 0.59
MAT2A P31153 1/20 0.42
SCN10A Q9Y5Y9 2/20 0.39
USP30 Q70CQ3 1/20 0.37
NPC1 O15118 1/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
ALOX15 P16050 1/20 0.37
NFKB1 P19838 1/20 0.37
SLC6A2 P23975 1/20 0.37
SCN4A P35499 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5956378 0.92 TGFBR1 (0.48) TGFBR1MAPK14MAT2ASCN10AUSP30
SCHEMBL5956379 0.92 TGFBR1 (0.48) TGFBR1MAPK14MAT2ASCN10AUSP30
SCHEMBL5956439 0.89 TGFBR1 (0.64) TGFBR1MAPK14NPC1RAB9ASMN1; SMN2
SCHEMBL5956501 0.82 TGFBR1 (0.56) TGFBR1MAPK14KDR
SCHEMBL5956446 0.80 TGFBR1 (0.61) TGFBR1MAPK14KDR
SCHEMBL5956677 0.79 TGFBR1 (0.52) TGFBR1MAPK14
SCHEMBL5956566 0.78 TGFBR1 (0.52) TGFBR1MAPK14KDR
SCHEMBL5907522 0.78 MAT2A (0.43) TGFBR1MAPK14MAT2ASCN10AUSP30
SCHEMBL5919686 0.77 MAT2A (0.46) TGFBR1MAPK14MAT2ASCN10AUSP30
SCHEMBL5956486 0.77 TGFBR1 (0.57) TGFBR1MAPK14NPC1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060004051-A1 Compounds DODIC NERINA 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004051-A1 Compounds SMAD3, SMAD2, TGFBR1 TGFBR1 3/4885MAPK14 297/4885MAT2A 1549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.